Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma

Figure 1 Differential expression of KIF21B in The Cancer Genome Atlas database and hepatocellular carcinoma cell lines. A and B: Differential expression levels of KIF21B in 50 pairs of matched hepatocellular carcinoma and adjacent normal tissues from the The Cancer Genome Atlas database (P < 0.01); C: KIF21B expression was examined in BEL-7404, BEL-7402, Hep-G2, SMMC-7721, and Chang liver cells. All the data were normalized to mRNA expression levels of human GAPDH using the 2^-ΔΔCT method. All the experiments were conducted in triplicate. Data were analyzed by ANOVA or t-test. The data are reported as the mean ± SD. P < 0.05 was considered significant, ^aP < 0.05, ^bP < 0.01.